EUVIMEDEUVIMED entdecken
Validierungsstudie

Validation of alopecia coding in US claims data among women of childbearing age

Maria C Schneeweiss iD, Arash Mostaghimi, Stephanie Chiuve iD, Sebastian Schneeweiss iD, Priyanka Anand iD, Katharina Schoder, Theresa Oduol, Carrie Huisingh, Kueiyu Joshua Lin

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5782 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Maria C Schneeweiss und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Alopecia Areata, International Classification of Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accurately identifying alopecia in claims data is important to study this rare medication side effect.

Objectives

To develop and validate a claims‐based algorithm to identify alopecia in women of childbearing age.

Methods

We linked electronic health records from a large healthcare system in Massachusetts (Mass General Brigham) with Medicaid claims data from 2016 through 2018 to identify all women aged 18 to 50 years with an ICD‐10 code for alopecia, including alopecia areata, androgenic alopecia, non‐scarring alopecia, or cicatricial alopecia, from a visit to the MGB system. Using eight predefined algorithms to identify alopecia in Medicaid claims data, we randomly selected 300 women for whom we reviewed their charts to validate the alopecia diagnosis. Positive predictive values (PPVs) were computed for the primary algorithm and seven algorithm variations, stratified by race.

Results

Out of 300 patients with at least 1 ICD‐10 code for alopecia in the Medicaid claims, 286 had chart‐confirmed alopecia (PPV = 95.3%). The algorithm requiring two diagnosis codes plus one prescription claim for alopecia treatment identified 55 patients (PPV = 100%). The algorithm requiring 1 diagnosis code for alopecia plus 1 procedure claim for intralesional triamcinolone injection identified 35 patients (PPV = 100%). Across all 8 algorithms tested, the PPV varied between 95.3% and 100%. The PPV for alopecia ranged from 94% to 100% in White and 96%–100% in 48 non‐White women. The exact date of alopecia onset was difficult to determine in charts.

Conclusion

At least one recorded ICD‐10 code for alopecia in claims data identified alopecia in women of childbearing age with high accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataInternational Classification of DiseasesFemaleHumansAlgorithmsDatabases, FactualElectronic Health RecordsPredictive Value of TestsUnited StatesAdolescentYoung AdultAdultMiddle Aged

Stichwörter der Autor:innen

ICD‐10US claims dataalopeciavalidationwomen of childbearing age

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • AbbVie, Inc., North Chicago, Illinois, USA.
  • Clinical Phenotyping and Outcome Validation Program, Mass General Brigham Center for Integrated Healthcare Data Research, Boston, Massachusetts, USA.
  • Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Maria C Schneeweiss, Stephanie Chiuve, Sebastian Schneeweiss, Priyanka Anand

Förderung

  • AbbVie

Zitieren

APA

Schneeweiss, M. C., Mostaghimi, A., Chiuve, S., Schneeweiss, S., Anand, P., Schoder, K., Oduol, T., Huisingh, C., & Lin, K. J. (2024). Validation of alopecia coding in US claims data among women of childbearing age. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5782

Vancouver

Schneeweiss MC, Mostaghimi A, Chiuve S, Schneeweiss S, Anand P, Schoder K, et al. Validation of alopecia coding in US claims data among women of childbearing age. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5782

BibTeX
@article{Schneeweiss2024,
  author = {Schneeweiss, Maria C and Mostaghimi, Arash and Chiuve, Stephanie and Schneeweiss, Sebastian and Anand, Priyanka and Schoder, Katharina and Oduol, Theresa and Huisingh, Carrie and Lin, Kueiyu Joshua},
  title = {Validation of alopecia coding in US claims data among women of childbearing age},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5782}
}
Kostenlos starten →